FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

900000000000526001: REPLACED BY association reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


23369 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set (foundation metadata concept) Is a Historical association reference set (foundation metadata concept) true Inferred relationship Some

Members targetComponentId
pT1c category American Joint Committee on Cancer pT1c (qualifier value)
pT1c: Tumor 10 mm or less in greatest diameter and 2.5 mm or less in greatest height (thickness) with macroscopic extraocular extension (ciliary body and choroid) (uveal melanoma) American Joint Committee on Cancer pT1c (qualifier value)
pT1c: Tumor 2 cm or less in greatest dimension, invading the subcutis and/or greater than 6 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) American Joint Committee on Cancer pT1c (qualifier value)
pT1c: Tumor limited to the iris with melanomalytic glaucoma (iris) (uveal melanoma) American Joint Committee on Cancer pT1c (qualifier value)
pT1c: Tumor more than 1 cm but not more than 2 cm in greatest dimension (breast) American Joint Committee on Cancer pT1c (qualifier value)
pT1mic category American Joint Committee on Cancer pT1mi (qualifier value)
pT1mic: Microinvasion 0.1 cm or less in greatest dimension (breast) American Joint Committee on Cancer pT1mi (qualifier value)
pT2 (II): Cervical carcinoma invades beyond uterus but not to pelvic wall or to lower third of vagina (TNM category and FIGO stage) (uterine cervix) American Joint Committee on Cancer pT2 (qualifier value)
pT2 (II): Tumor confined to the vulva or vulva and perineum, more than 2 cm in greatest dimension (TNM category and FIGO stage) (vulva) American Joint Committee on Cancer pT2 (qualifier value)
pT2 (II): Tumor extends outside of uterus but limited to genital structures (ovary, tube, vagina, broad ligaments) (TNM category and FIGO stage) (gestational trophoblast) American Joint Committee on Cancer pT2 (qualifier value)
pT2 (II): Tumor invades cervix but does not extend beyond uterus (TNM category and FIGO stage) (corpus uteri) American Joint Committee on Cancer pT2 (qualifier value)
pT2 (II): Tumor invades paravaginal tissues but not to pelvic wall (TNM category and FIGO stage) (vagina) American Joint Committee on Cancer pT2 (qualifier value)
pT2 (II): Tumor involves one or both fallopian tubes with pelvic extension (TNM category and FIGO stage) (fallopian tube) American Joint Committee on Cancer pT2 (qualifier value)
pT2 (II): Tumor involves one or both ovaries with pelvic extension AND/OR implants (TNM category and FIGO stage) (ovary) American Joint Committee on Cancer pT2 (qualifier value)
pT2 category American Joint Committee on Cancer pT2 (qualifier value)
pT2: Melanoma 1.01 to 2.0 mm in thickness, with or without ulceration (melanoma of the skin) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Minimal invasion of the optic nerve and/or optic coats (retinoblastoma) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Organ confined (prostate) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Solitary tumor with vascular invasion or multiple tumors none more than 5 cm (liver, including intrahepatic bile ducts) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor causing bone erosion or destruction including extension into the hard palate and/or middle nasal meatus, except extension to posterior wall of maxillary sinus and pterygoid plates (maxillary sinus) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor confluent with or extending into the ciliary body and/or choroid (iris) (uveal melanoma) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor extends to the soft tissues (nasopharynx) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor extends to the supraglottis AND/OR subglottis, AND/OR with impaired vocal cord mobility (larynx, glottis) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor extends to vocal cord(s) with normal or impaired mobility (larynx, subglottis) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor greater than 10 mm but not more than 16 mm in greatest basal diameter and between 2.5 and 10 mm in maximum height (thickness) (ciliary body and choroid) (uveal melanoma) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor invades beyond the wall of bile duct (extrahepatic bile ducts) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor invades duodenal wall (ampulla of Vater) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor invades more than one subsite of hypopharynx or an adjacent site, or measures more than 2 cm but not more than 4 cm in greatest diameter without fixation of hemilarynx (hypopharynx) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor invades mucosa of more than one adjacent subsite of supraglottis or glottis or region outside the supraglottis (e.g., mucosa of base of tongue, vallecula, medial wall of pyriform sinus) without fixation of the larynx American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor invades muscularis (renal pelvis and ureter) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor invades muscularis propria (appendix) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor invades muscularis propria (colon/rectum) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor invades muscularis propria (esophagus) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor invades muscularis propria (small intestine) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor invades muscularis propria (urinary bladder, ureter, renal pelvis) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor invades muscularis propria or subserosa (stomach) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor invades perimuscular connective tissue; no extension beyond serosa or into liver (gallbladder) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor invading two subsites in a single region or extending to involve an adjacent region within the nasoethmoidal complex, with or without bony invasion (nasal cavity and ethmoid sinus) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor involves any of the ipsilateral pleural surfaces with at least one of the following: confluent visceral pleural tumor (including fissure), invasion of diaphragmatic muscle, invasion of lung parenchyma (thoracic mesothelioma) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor limited to the pancreas, more than 2 cm in greatest dimension (exocrine pancreas) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor limited to the testis and epididymis with vascular/lymphatic invasion, or tumor extending through the tunica albuginea with involvement of the tunica vaginalis (testis) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension (lip and oral cavity) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension (oropharynx) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension limited to the thyroid (thyroid) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension without extraparenchymal extension (major salivary glands) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor more than 2 cm but not more than 5 cm in greatest dimension (anal canal) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor more than 2 cm but not more than 5 cm in greatest dimension (breast) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor more than 2 cm, but not more than 5 cm, in greatest dimension (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor more than 5 cm in greatest dimension (extraosseous primitive neuroectodermal tumor/Ewing's sarcoma) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor more than 7 cm in greatest dimension, limited to the kidney (kidney) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor more than 8 cm in greatest dimension (bone) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor more than 8 cm in greatest dimension (osseous primitive neuroectodermal tumor/Ewing's sarcoma) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor of lung as per American Joint Committee on Cancer 6th Edition definition (lung) American Joint Committee on Cancer pT2 (qualifier value)
pT2a (IIA): Extension to AND/OR implants on uterus AND/OR tube(s). No malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (ovary) American Joint Committee on Cancer pT2a (qualifier value)
pT2a (IIA): Tumor involves one or both fallopian tubes with extension and/or metastasis to the uterus and/or ovaries (TNM category and FIGO stage) (fallopian tube) American Joint Committee on Cancer pT2a (qualifier value)
pT2a (IIA): Tumor limited to the glandular epithelium of the endocervix. There is no evidence of connective tissue stromal invasion (TNM category and FIGO stage) (corpus uteri) American Joint Committee on Cancer pT2a (qualifier value)
pT2a (IIA): Tumor without parametrial invasion (TNM category and FIGO stage) (uterine cervix) American Joint Committee on Cancer pT2a (qualifier value)
pT2a category American Joint Committee on Cancer pT2a (qualifier value)
pT2a: Melanoma 1.01 to 2.0 mm in thickness, no ulceration (melanoma of the skin) American Joint Committee on Cancer pT2a (qualifier value)
pT2a: Tumor 10 mm to 16 mm in greatest basal diameter and between 2.5 and 10 mm in maximum height (thickness) without microscopic extraocular extension (ciliary body and choroid) (uveal melanoma) American Joint Committee on Cancer pT2a (qualifier value)
pT2a: Tumor confluent with or extending into the ciliary body and/or choroid with melanomalytic glaucoma (iris) (uveal melanoma) American Joint Committee on Cancer pT2a (qualifier value)
pT2a: Tumor extends to the soft tissues of the oropharnyx and/or nasal cavity without parapharyngeal extension (nasopharynx) American Joint Committee on Cancer pT2a (qualifier value)
pT2a: Tumor invades muscularis propria (stomach) American Joint Committee on Cancer pT2a (qualifier value)
pT2a: Tumor invades optic nerve up to, but not through, the level of the lamina cribrosa (retinoblastoma) American Joint Committee on Cancer pT2a (qualifier value)
pT2a: Tumor invades superficial muscle (inner half) (urinary bladder) American Joint Committee on Cancer pT2a (qualifier value)
pT2a: Tumor more than 2 cm, but not more than 5 cm, in greatest dimension, limited to dermis or greater than 2 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) American Joint Committee on Cancer pT2a (qualifier value)
pT2a: Tumor more than 5 cm in greatest dimension, superficial tumor (extraosseous primitive neuroectodermal tumor/Ewing's sarcoma) American Joint Committee on Cancer pT2a (qualifier value)
pT2a: Tumor more than 5 cm in greatest dimension, superficial tumor (soft tissue) American Joint Committee on Cancer pT2a (qualifier value)
pT2a: Unilateral, one-half of one lobe or less (prostate) American Joint Committee on Cancer pT2a (qualifier value)
pT2b (IIB): Extension to AND/OR implants on other pelvic tissues. No malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (ovary) American Joint Committee on Cancer pT2b (qualifier value)
pT2b (IIB): Invasion of the stromal connective tissue of the cervix (TNM category and FIGO stage) (corpus uteri) American Joint Committee on Cancer pT2b (qualifier value)
pT2b (IIB): Tumor involves one or both fallopian tubes with extension to other pelvic structures (TNM category and FIGO stage) (fallopian tube) American Joint Committee on Cancer pT2b (qualifier value)
pT2b (IIB): Tumor with parametrial invasion (TNM category and FIGO stage) (uterine cervix) American Joint Committee on Cancer pT2b (qualifier value)
pT2b category American Joint Committee on Cancer pT2b (qualifier value)
pT2b: Melanoma 1.01 to 2.0 mm in thickness, with ulceration (melanoma of the skin) American Joint Committee on Cancer pT2b (qualifier value)
pT2b: Tumor 10 mm to 16 mm in greatest basal diameter and between 2.5 and 10 mm in maximum height (thickness) with microscopic extraocular extension (ciliary body and choroid) (uveal melanoma) American Joint Committee on Cancer pT2b (qualifier value)
pT2b: Tumor extends to the soft tissues of the oropharnyx and/or nasal cavity with parapharyngeal extension (nasopharynx) American Joint Committee on Cancer pT2b (qualifier value)
pT2b: Tumor invades choroid focally (retinoblastoma) American Joint Committee on Cancer pT2b (qualifier value)
pT2b: Tumor invades deep muscle (outer half) (urinary bladder) American Joint Committee on Cancer pT2b (qualifier value)
pT2b: Tumor invades subserosa (stomach) American Joint Committee on Cancer pT2b (qualifier value)
pT2b: Tumor more than 2 cm, but not more than 5 cm, in greatest dimension, limited to dermis and greater than 2 mm in thickness, but not more than 6 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) American Joint Committee on Cancer pT2b (qualifier value)
pT2b: Tumor more than 5 cm in greatest dimension, deep tumor (extraosseous primitive neuroectodermal tumor/Ewing's sarcoma) American Joint Committee on Cancer pT2b (qualifier value)
pT2b: Tumor more than 5 cm in greatest dimension, deep tumor (soft tissue) American Joint Committee on Cancer pT2b (qualifier value)
pT2b: Unilateral, involving more than one-half of lobe but not both lobes (prostate) American Joint Committee on Cancer pT2b (qualifier value)
pT2c (IIC): Pelvic extension AND/OR implants (T2a or T2b/IIA or IIB) with malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (ovary) American Joint Committee on Cancer pT2c (qualifier value)
pT2c (IIC): Tumor involves one or both fallopian tubes with pelvic extension with malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (fallopian tube) American Joint Committee on Cancer pT2c (qualifier value)
pT2c category American Joint Committee on Cancer pT2c (qualifier value)
pT2c: Bilateral disease (prostate) American Joint Committee on Cancer pT2c (qualifier value)
pT2c: Tumor 10 mm to 16 mm in greatest basal diameter and between 2.5 and 10 mm in maximum height (thickness) with macroscopic extraocular extension (ciliary body and choroid) (uveal melanoma) American Joint Committee on Cancer pT2c (qualifier value)
pT2c: Tumor invades optic nerve up to, but not through, the level of the lamina cribrosa and invades the choroid focally (retinoblastoma) American Joint Committee on Cancer pT2c (qualifier value)
pT2c: Tumor more than 2 cm, but not more than 5 cm, in greatest dimension, invading the subcutis and/or greater than 6 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) American Joint Committee on Cancer pT2c (qualifier value)
pT3 (III): Local and/or regional spread as specified in pT3a, pT3b, pN1, and FIGO IIIA, IIIB, and IIIC (TNM category and FIGO stage) (corpus uteri) American Joint Committee on Cancer pT3 (qualifier value)
pT3 (III): Tumor extends to pelvic wall (TNM category and FIGO stage) (vagina) American Joint Committee on Cancer pT3 (qualifier value)
pT3 (III): Tumor extends to pelvic wall and/or involves lower third of vagina and/or causes hydronephrosis or non-functioning kidney (TNM category and FIGO stage) (uterine cervix) American Joint Committee on Cancer pT3 (qualifier value)
pT3 (III): Tumor involves one or both fallopian tubes, with peritoneal implants outside the pelvis (TNM category and FIGO stage) (fallopian tube) American Joint Committee on Cancer pT3 (qualifier value)
pT3 (III): Tumor of any size with contiguous spread to the lower urethra and/or vagina or anus (TNM category and FIGO stage) (vulva) American Joint Committee on Cancer pT3 (qualifier value)
pT3 and/or N1 (III): Tumor involves one or both fallopian tubes, with peritoneal implants outside the pelvis AND/OR regional lymph node metastasis (TNM category and FIGO stage) (fallopian tube) American Joint Committee on Cancer pT3 (qualifier value)
pT3 and/or N1 (III): Tumor involves one or both ovaries with microscopically confirmed peritoneal metastasis outside the pelvis (including liver capsule metastasis) and/or regional lymph node metastasis (TNM category and FIGO stage) (ovary) American Joint Committee on Cancer pT3 (qualifier value)
pT3 category American Joint Committee on Cancer pT3 (qualifier value)
pT3: Discontinuous tumors in the primary bone site (bone) American Joint Committee on Cancer pT3 (qualifier value)
pT3: Discontinuous tumors in the primary bone site (osseous primitive neuroectodermal tumor/Ewing's sarcoma) American Joint Committee on Cancer pT3 (qualifier value)

Start Previous Page 232 of 234 Next End


Reference Sets

Reference set descriptor

Back to Start